RET and breast carcinoma: Taking into account the data for breast cancer samples described above, it is obvious that a more detailed characterization of biopsies from patients with pancreatic, prostate, and other cancers for the expression of components of GFL signaling complex using more reliable methods of mRNA level analysis can actually change the overall impression regarding the role of RET in these malignancies.